Cvac as Maintenance Treatment in Patients With Epithelial Ovarian Cancer in Complete Remission Following First-line Chemotherapy or Second-line Treatment
Stopped The study was terminated due to company restructuring and changes in drug development priorities.
Conditions
- Epithelial Ovarian Cancer
Interventions
- BIOLOGICAL: Cvac
- BIOLOGICAL: Placebo
Sponsor
Prima BioMed Ltd